Asston Pharmaceuticals logo

Asston Pharmaceuticals results, half year to Mar 2026

BSE: 544445Pharmaceuticals & BiotechnologySmall Cap

ASSTON PHARMACEUTICALS LIMITED · Face value ₹10 · Listed Jul 2025
Last close ₹146.25up ₹5.17 (3.66%)

Share price at the BSE close on 28 Oct 2026. Previous close ₹141.08.

28 Oct: open ₹140.50, high ₹148.00, low ₹140.50

52-week range of traded prices to 28 Oct 2026
₹60.00Low, 21 Jul 2026₹148.00High, 28 Oct 2026
Market cap
₹160 Cr3,188th largest listed
P/E
308.99
P/E without one-offs
41.33
P/B
Shares changed
Dividend yield
Nonein the last 12 months
ROE
1.3%
ROE without one-offs
9.9%
ROCE
−2.0%
Debt to equity
0.13
Volume, BSE
50,000

Asston Pharmaceuticals filed its results for the half year to Mar 2026 on 29 May 2026 at 10:08 pm, standalone: the listed company alone, without its subsidiaries.

Results for the half year to Mar 2026

₹ crore.Asston Pharmaceuticals annual results and balance sheet

Revenue
₹10 Cr−34.8% on the half year before
Operating profit
−₹2.80 Cr
Net profit
₹0.48 Cr+1,320.6% on the half year before
Operating margin
−27.8%
Net margin
4.8%

From revenue to net profit, ₹ crore

  1. Revenue10
  2. Materials and goods−8.4
  3. Employee costs−2.0
  4. Other expenses−2.4
  5. Operating profit−2.8
  6. Depreciation−0.3
  7. Other income+4.6
  8. Finance costs−0.4
  9. Profit before tax1.2
  10. Tax−0.7
  11. Net profit0.5

Asston Pharmaceuticals results by half year

Standalone: the listed company alone, without its subsidiaries. Latest half year to Mar 2026. Results for the half year to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by half year, ₹ crore

  • Revenue
  • Net profit
150.0Sep 25100.5Mar 26
Peak revenue ₹15 Cr, half year to Sep 2025; lowest ₹10 Cr, half year to Mar 2026

Operating and net margin by half year, per cent

  • Operating margin
  • Net margin
14.5%−27.8%14.5%−27.8%0.2%4.8%Sep 25Mar 26
₹ croreSep 2025Filed 14 NovMar 2026Filed 29 May
Revenue from operations15.410.1
13.212.9
Materials and goods bought9.08.4
Employee costs0.62.0
Other expenses3.62.4
Operating profit before depreciation2.2−2.8
Operating margin14.5%−27.8%
Depreciation and amortisation0.10.3
Other income1.54.6
Finance costs0.30.4
Profit before one-off items and tax3.41.2
One-off items−3.30.0
Profit before tax0.01.2
0.00.7
Tax rate−36.0%60.4%
Net profit0.00.5
Net margin0.2%4.8%
Earnings per share₹0.05–
Earnings per share in rupees, restated for later splits and bonuses.